DN
DNA Group (T.R.) Ltd.
DNA | TA
Overview
Corporate Details
- ISIN(s):
- IL0011038523
- LEI:
- Country:
- Israel
- Address:
- Shimon Hatars' 43, 6249245 Tel Aviv
- Website:
- http://www.dnas.co.il
- Sector:
- Professional, scientific and technical activities
- Industry:
- Research and experimental development on natural sciences and engineering
Description
DNA Group develops and markets technological solutions for defense and homeland security sectors.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
You have of free filing views remaining.
Upgrade for unlimited access.
Bulk Actions:
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-11-10 18:41 |
M&A Activity
Following the completion of a Big Allotment and in light of the company's compl…
|
English | 156.3 KB | ||
| 2025-11-10 17:02 |
Regulatory News Service
Zero Weight Cap Factor in TASE Indices
|
English | 116.1 KB | ||
| 2025-11-10 16:10 |
Delisting Announcement
Base price of 1 agora and unlimited price fluctuation
|
English | 91.6 KB | ||
| 2022-11-06 14:35 |
Regulatory News Service
Changes in the company's names and security names , effective as of f November …
|
Hebrew (modern) | 149.0 KB | ||
| 2021-07-29 21:13 |
Regulatory News Service
Termination of coverage report
|
Hebrew (modern) | 174.5 KB | ||
| 2021-07-29 21:13 |
Notice of Dividend Amount
Termination of coverage report
|
Russian | 101.2 KB | ||
| 2021-06-13 10:10 |
Regulatory News Service
update Analysis (FROST) following financial report, target price remains at NIS…
|
English | 1.1 MB | ||
| 2021-06-13 10:10 |
Investor Presentation
update Analysis (FROST) following financial report, target price remains at NIS…
|
Russian | 101.2 KB | ||
| 2021-04-11 22:23 |
Earnings Release
update Analysis (FROST) following financial report 2020,target price remains at…
|
English | 1.1 MB | ||
| 2021-04-11 22:23 |
Pre-Annual General Meeting Information
update Analysis (FROST) following financial report 2020,target price remains at…
|
Russian | 98.1 KB | ||
| 2020-12-16 19:22 |
Investor Presentation
Analysis update following financial report:price target is unchanged NIS 2.62
|
English | 1.1 MB | ||
| 2020-12-16 19:22 |
Investor Presentation
Analysis update following financial report:price target is unchanged NIS 2.62
|
Russian | 94.7 KB | ||
| 2020-09-01 21:58 |
Regulatory News Service
Analysis update following financial report:price target is unchanged NIS 2.62
|
English | 1.1 MB | ||
| 2020-09-01 21:58 |
Environmental & Social Information
Analysis update following financial report:price target is unchanged NIS 2.62
|
Russian | 94.7 KB | ||
| 2020-08-24 21:06 |
Earnings Release
update analsis (FORST),price target is unchanged
|
English | 1.1 MB |
Automate Your Workflow. Get a real-time feed of all DNA Group (T.R.) Ltd. filings delivered via API.
Market Data
Market Data Not Available
Last Price
Change / %
Market Cap
N/A
Volume
Day High
Day Low
52W High
52W Low
Financials & KPIs
No data available
Unlock Full Financials for DNA Group (T.R.) Ltd.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for DNA Group (T.R.) Ltd. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
Company
Country
Ticker
View
Developing sulforaphane-based therapeutics for oncology and behavioural brain disorders.
United Kingdom
TCF
United Kingdom
TCF
Developing immune therapies for rare autoimmune diseases like myasthenia gravis.
Sweden
TOL
Sweden
TOL
A nonprofit consortium managing atmospheric research and providing resources to the scientific community.
France
ALUCR
France
ALUCR
AI-powered diagnostic tests for the kidney transplant market, predicting organ rejection and injury.
United Kingdom
VRCI
United Kingdom
VRCI
Develops AT2 receptor drugs and a digital therapeutic for pulmonary fibrosis.
Sweden
VICO
Sweden
VICO
Slovakia
0OCW
A life sciences incubator commercializing early-stage academic research for healthcare markets.
Switzerland
XLS
Switzerland
XLS
A tech fund incubating MedTech, biotech, and defense ventures with investment and IP protection.
Poland
YOS
Poland
YOS